Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- File Type
Articles 1 - 3 of 3
Full-Text Articles in Entire DC Network
Whole-Food Plant-Based Diet Impact On Chronic Disease Reversal, Veena Patel
Whole-Food Plant-Based Diet Impact On Chronic Disease Reversal, Veena Patel
Capstone Showcase
This article delves into the prevalence and costs associated with various chronic diseases, elucidates how adopting a whole food plant-based (WFPB) diet can effectively combat these ailments, and offers resources and guidance for healthcare providers to engage in discussions about WFPB diets with their patients. A WFPB diet centers around unprocessed, natural foods like fruits, vegetables, whole grains, legumes, nuts, and seeds, while eschewing animal based products. This dietary regimen prioritizes nutrient-rich, plant-derived foods, favoring minimally processed options to enhance overall health and vitality. Its design is deliberate, offering a therapeutic approach to tackling chronic diseases and fostering recovery. By …
In Patients With Hepatocellular Carcinoma (Hcc) (P), Is Bevacizumab With Atezolizumab (I) More Effective Than Sorafenib (C) In Long-Term Clinical Prognosis (O)?, Joon Lee
Capstone Showcase
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death globally. China contributes to half of the global incidence of liver cancer, with about 70-85% being HCC. Definitive treatment for this condition would be surgical resection with liver transplant but for obvious reasons, the majority of affected patients are unable to meet the necessary criteria. Sorafenib is a form of chemotherapy that has been the mainstay treatment of HCC since its approval in 2007. More recently, the combination of Bevacizumab and Atezolizumab has shown greater efficacy in the treatment of unresectable HCC. Additionally, this new combination therapy shows favorable …
Detecting Multiple Myeloma In The Primary Care Setting, Anna Schweidler
Detecting Multiple Myeloma In The Primary Care Setting, Anna Schweidler
Capstone Showcase
Multiple myeloma (MM) is a hematological malignancy arising from differentiated B-lymphocyte white blood cells called plasma cells. Hematological malignancies are the fourth most diagnosed cancers, composing approximately 9% of all cancer diagnoses. Specifically, multiple myeloma attributes to approximately 2% of cancer diagnoses in the United States2. MM incidence has increased significantly over the past years, increasing 40% in the United States and 126% globally from 1990-2016 2. Affecting 7.0 out of every 100,000 people2, multiple myeloma is considered a rare form of blood cancer. Many strides have been made in the treatment of multiple myeloma …